Singular Genomics | PREM14A: Preliminary proxy statements relating to merger or acquisition
Singular Genomics | SCHEDULE 13D/A: Others
Singular Genomics | DEFA14A: Others
Singular Genomics | 8-K: Current report
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Meeter Dalen
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRCM Institutional Master Fund (BVI), Ltd.(4.61%),CRCM LP(4.61%), etc.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ghai Jyotsna
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Meeter Dalen
Singular Genomics | 10-Q: Q3 2024 Earnings Report
Singular Genomics | 8-K: Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
Singular Genomics | SC 13D: Statement of acquisition of beneficial ownership by individuals-CRCM Institutional Master Fund (BVI), Ltd.(5.6%),CRCM LP(5.6%), etc.
Singular Genomics | 8-K: Current report
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ghai Jyotsna
Singular Genomics | 8-K: Current report
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-10% Owner TANG KEVIN